BRTX — BioRestorative Therapies, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1505497 ·
Last close
$2.55
Market Cap
$3.52M
52W High
$2.93
52W Low
$0.14
ADV30
258,140
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 23,170 | 15,785 | -3,385,733 | -2,154,405 | 4,640,279 | 3,112,679 | 1,614,637 |
| Dec 2025 | 19,600 | 17,964 | -3,825,300 | -3,207,636 | 4,079,635 | 1,511,188 | 3,722,891 |
| Sep 2025 | 11,800 | 1,230 | -3,709,011 | -3,038,277 | 5,642,662 | 602,444 | 3,435,683 |
| Jun 2025 | 303,300 | 294,571 | -3,305,287 | -2,656,263 | 8,516,559 | 1,555,251 | 3,671,235 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,817,969
Investing CF
$7,498,950
Financing CF
$6,202,909
CapEx
$-128,503
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.39
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-172,075,095
Inventory
—
Receivables
$13,300
ST Investments
$479,351
EBIT TTM
$-14,225,331
Pretax Income TTM
$-11,056,581
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$357,870
EBITDA
$-14,014,733
Free Cash Flow
$-9,714,683
Enterprise Value
$-161,918
Total Cash
$3,592,030
Total Debt
$28,774
Shares Out
1,381,128
Trailing EPS
$-21.20
Book Value
$2.38
ROE
-241.1%
ROA
-118.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 359,700 | -15,647,132 | -14,241,975 | 4,079,635 | 3,722,891 | 356,744 | -10,788,963 |
| Dec 2024 | 401,000 | -11,555,194 | -8,979,381 | 12,279,799 | 3,748,406 | 8,531,393 | -8,230,346 |
| Dec 2023 | 145,800 | -15,137,441 | -10,417,704 | 12,611,720 | 2,607,345 | 10,004,375 | -6,430,211 |
| Dec 2022 | 119,800 | -18,863,507 | -13,222,296 | 16,434,691 | 6,144,352 | 10,290,339 | -5,913,100 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-10.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp | $4.08M | $1.39 | — |
| ATPC | Agape ATP Corp | $2.24M | $2.24 | — |
| BMGL | Basel Medical Group Ltd | $5.79M | $3.70 | — |
| HLYK | HealthLynked Corp | $5.81M | $1.97 | — |
| BICX | BioCorRx Inc. | $5.98M | $0.20 | — |
News headlines (Yahoo Finance, 1h cache)
BioRestorative Therapies Announces Reverse Stock Split
2026-09-02 21:27 · Yahoo
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
2026-06-25 12:15 · Yahoo
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic
2026-06-18 12:15 · Yahoo
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
2026-05-27 11:45 · Yahoo
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
2026-05-26 15:00 · Yahoo
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
2026-05-15 16:00 · Yahoo
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 23:40 · Yahoo
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
2026-05-13 15:00 · Yahoo
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
2026-05-07 16:00 · Yahoo
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
2026-04-30 14:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.